Emotional Assessment and Tiered Individualized Psychological Support of the Artificial Intelligence Robot
1 other identifier
interventional
130
1 country
1
Brief Summary
To develop the E-MOTE robot and evaluate its effectiveness in addressing psychological distress, physical symptom, stress index, and quality of life, as well as to explore its clinical applicability.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2025
CompletedStudy Start
First participant enrolled
October 1, 2025
CompletedFirst Posted
Study publicly available on registry
January 26, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
January 26, 2026
October 1, 2025
10 months
July 25, 2025
January 19, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Distress
Investigators utilized the Distress Thermometer(DT) as the primary outcome measure. The scale uses a 11 Liker scale, where 0 indicates no distress at all and 10 represents the most severe distress.Higher score indicates a more severe distress. When the score is 4 or higher, a Problem List (PL) is used to further identify factors contributing to the emotional distress.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge.
Depression
Investigators utilized the Patient Health Questionnaire (PHQ-9) as the primary outcome measure to assess depression. The scale consists of 9 items, each rated on a 4-point Likert scale (0 = not at all, 3 = nearly every day). The total score ranges from 0 to 27, and depression severity can be categorized as mild (5-9), moderate (10-14), moderately severe (15-19), and severe (20 or above).Higher score indicates a more severe depression.
Measurements will be taken before the intervention, three days after surgery, and one week after discharge.
Secondary Outcomes (5)
Usability of the robot
Measurements will be taken three days post-surgery.
Quality of Life Measurement
Measurements will be taken before the intervention, three days after surgery, and one week after discharge.
Loneliness
Measurements will be taken before the intervention, three days after surgery, and one week after discharge.
Symptom Severity
Measurements will be taken before the intervention, three days after surgery, and one week after discharge.
Physiological objective indicators
Measurements will be taken before the intervention, three days after surgery, and one week after discharge.
Study Arms (2)
Control Group
NO INTERVENTIONRoutine care
Intervention Group
EXPERIMENTALThe intervention group will receive the E-MOTE robot, which conducts emotional assessments, and provides a session of self-affirmation relaxation training followed by a Q\&A session.
Interventions
Participants in the experimental group will receive the E-MOTE robot intervention on the first and second days after surgery. The intervention includes an emotional assessment, followed by appropriate dialogue modules tailored to the level of emotional distress. These are supplemented with emotion-generated empathetic conversations for deeper engagement, a session of self-affirmation relaxation training, and a subsequent Q\&A session.
Eligibility Criteria
You may qualify if:
- Aged 18 years or older.
- Diagnosed with gynecologic cancer and undergoing surgery.
- Willing to receive E-MOTE robot and wear a smart wearable device.
- Willing to complete pre-test and post-test questionnaires.
You may not qualify if:
- Unable to communicate clearly.
- Unwilling or unable to participate in the study in its entirety.
- \*\*\*Nurse\*\*\*
- Aged 18 years or older.
- As a clinical nurse and has cared for patients who received the E-MOTE robot
- \- Unwilling to participate in the qualitative interview.
- Stage 2 (only for patients) \*\*\*Intervention group\*\*\*
- Aged 18 years or older.
- Diagnosed with gynecologic cancer and scheduled to undergo surgery.
- Willing to receiveE-MOTE robot and to wear a smart wearable device.
- Willing to complete pre-test and post-test questionnaires.
- Unable to communicate clearly.
- Unwilling or unable to participate in the study in its entirety.
- \*\*\*Control group\*\*\*
- Aged 18 years or older.
- +4 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
National Taiwan University
Taipei, Taiwan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2025
First Posted
January 26, 2026
Study Start
October 1, 2025
Primary Completion (Estimated)
July 31, 2026
Study Completion (Estimated)
July 31, 2026
Last Updated
January 26, 2026
Record last verified: 2025-10